This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The use of specialty medicine has grown rapidly in recent decades, fueling parallel growth in the number of specialtypharmacies that serve patients who are prescribed specialty medications. Results of this work were published in the Journal of Managed Care & SpecialtyPharmacy in October 2022.
While SaveOnSP is the nominal target of the lawsuit, it claims to expose one of the failings in the US health insurance sector, adding fire to an increasingly heated exchange between pharma manufacturers and pharmacy benefit managers (PBMs), which have blamed each other for high medicine prices in the US.
According to court documents cited by Reuters, annual sales of Exforge in the US were over $400 million before generic versions reached the market. In 2020, it also paid $345 million to resolve a series of cases brought by the federal government under the Foreign Corrupt Practices Act (FCPA).
Today, we published the 2024 PQA Annual Report, which documents our progress towards our strategic goals. Successfully piloting pharmacy measure concepts focused on blood pressure and A1c improvement and control. Successfully piloting PQA’s endorsed measure focused on specialtypharmacy turnaround time.
As a specialty medication , Humira requires specific handling, administration, and monitoring, so you have to get it from a specialtypharmacy or other designated location. It’s also a good idea to review your Summary of Benefits and Coverage document to fully grasp the expenses,” Dr. Youssouf says.
The SpecialtyPharmacy Abandonment Rate TEP will define a measure around primary abandonment rate of specialtypharmacy prescriptions. The Health Equity TEP will review how PQA measures can be a tool to foster health equity by producing recommendations related to stratification for quality measures.
Chief Executive Officer Micah Cost opened the summit with an update on the state of the alliance. Cost highlighted progress towards completion of PQA’s strategic plan, Blueprint PQA 2025. Each panel session featured PQA staff and pilot project participants or other industry leaders, who detailed their approach, experience and outcomes.
Ensuring the quality of medication use is critically important for rare disease patients, payers, clinicians, specialtypharmacies and everyone with a role in the care process. February 29 was Rare Disease Day, providing an opportunity to raise awareness of the impact of rare diseases.
We continue to play a central role in driving meaningful improvements and positive changes related to medication safety, adherence and appropriate use.The 2023 PQA Annual Report documents our progress towards Blueprint PQA 2025. The data can also show short term results.
In some cases, however, it might mean your healthcare provider needs to submit documentation of symptoms, specialist visits, or other information to BCBS. However, they only apply for drugs you get from the pharmacy. In others, you might need to try other medications first, which is a process called step therapy.
Prior authorization might require the healthcare provider to submit documentation of your symptoms, diagnosis, specialist visits, or other information. Specialty drug requirements Specialty drugs are expensive medications used to treat complex conditions. Arora says that it’s often required due to the cost of the medication.
Jangus Whitner, Director of Pharmacy Services at PrimaryOne Health also shared the results of a qualitative research study that documented direct patient experiences using the 340B program on injectable diabetes medications. Omnicell can be a valued partner in this effort.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content